v3.22.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Operating activities:    
Net loss $ (8,702,746) $ (12,585,579)
Reconciliation of net loss to net cash from operating activities:    
Depreciation and amortization 89,713 119,664
Interest expense 573,965 265,566
Impairment of goodwill & intangible assets 5,200,608 7,182,053
Share based compensation expense 319,005 719,048
Gain on extinguishment of debt (459,912) 0
Issuance of common shares in lieu of services 33,000 0
Changes in non-cash working capital items    
Accounts receivable 322,131 672,660
Prepaid expenses and other current assets 188,373 (25,922)
Net book value of demonstration inventory sold 16,248 0
Due from related parties 0 (2,314)
Inventories (237,029) 219,910
Accounts payable (272,570) (318,480)
Accrued liabilities 166,825 420,139
Deferred revenue (4,928) (3,282)
Net cash used in operating activities (2,767,317) (3,336,537)
Investing activities:    
Purchases of equipment (12,500) 0
Net cash used in investing activities (12,500) 0
Financing activities:    
Proceeds from convertible loans 5,550,000 1,502,575
Proceeds from PPP loan 0 459,912
Payments on capital lease obligations (1,437) 0
Net cash provided by financing activities 5,548,563 1,962,487
Effect of exchange rate changes on cash and cash equivalents (7,102) 0
Net increase (decrease) in cash and cash equivalents 2,761,644 (1,374,050)
Cash and cash equivalents, beginning of the period 608,348 2,269,747
Cash and cash equivalents, end of the period 3,369,992 895,697
Cash and cash equivalents, beginning of the period 608,348  
Cash and cash equivalents, end of the period 3,369,992  
Supplemental noncash financing activities:    
Conversion of term loans into option exercises 642,153 0
Conversion of demand loans into convertible notes $ 3,286,791 $ 0

Source